Pfizer's business may be in better shape than investors think.
Maybe you’ve bought shares of AI company stocks or invested in ETFs focused on AI, technology, or computer science. Or, ...
A symbol of American pharmaceutical innovation for nearly two centuries, Pfizer now faces the challenges of AI adoption and the promise of smarter medicines. Pfizer CEO Albert Bourla discussed ...
By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...
Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...